Épisode 23 - Andrew Dudum : fondateur et PDG de Hims & Hers

Hims & Hers: Ein Fallendes Messer oder Die Beste Gelegenheit des Jahres?

Cet analyste vient de fixer un objectif de cours ÉNORME pour HIMS

Ep 26 - Martin Shkreli: The Case for Hims & Hers

Hims FINALLY Sells Lilly's GLP-1s! BEST NEWS IN 2 YEARS: Why this is A HUGE DEAL (Stock Down...)

Brian Birnbaum - Analyse des résultats du premier trimestre de Hims & Hers et perspectives haussi...

Hims Stock REBOUNDS! Still Cheap, LT & 2026 Revenue Growth is Sandbagged—Subscription A No-Brainer?

Hims & Hers 2025 Recap + 2026 Predictions

HIMS Stock is Fire - But why?

Hims Stock Launches Custom Testosterone Pill: Why It's a Huge Market + Labs + Future of Healthcare!

How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum

🚨 NOVO NORDISK SUES HIMS & HERS — Patent attorney Gaston Kroub breaks it down

HIMS Stock: Don’t Buy the Dip Until You See This

Big UP day for Oscar & Hims: TradHealth Disruptors' Time to Shine? Still Dirt Cheap? OSCR HIMS Stock

Hims Stock: Peptides Are Coming...

Hims Stock +7% on Insider Buy! This Volatile Stock Is Still Too Cheap.. + Latest CEO Interview Takes

HIMS Stock Analysis Can HIMS Break $30 Next? $40 Target Still Possible? EP. 394 #HIMS #HIMSStock

Hims Stock Below $30... Debunking the FUD, Valuation & More. Why Most Still Don't Understand Hims..

Hims Stock Down on Outstanding Execution: Eucalyptus Deal Closes WAY early! Outlook TOO SANDBAGGED!

Hims Stock: Debunking the GLP-1 FUD Again! What The Competition Doesn't Get..

Ep 32 - Antonio Linares Makes the Case for Hims as a 100x — From Here

Hims Stock SURGES +40% After Hours! NVO x HIMS PARTNERSHIP BACK! Research WINS+Squeeze Will be EPIC!

Hims Stock Acquires Eucalyptus for CHEAP: Big Tech Play, Most Hated Disruptor—A Giant in the Making.

Hims Stock: Short Squeeze Accelerates, +10%! Going Thru the FULL Thesis ONCE MORE! (Way Too Cheap!)

Hims Stock Up +13% in Pre-Q1 Earnings Run—What Does The Market Know? Bullish Signs?

Hims Stock Is So Cheap & The Market Has No Idea! From 27 to 19 in 2 weeks—All Novo Gains Are Gone..

HIMS Stock After Earnings: My Complete Analysis & Exit

Hims Stock STUNS THE MARKET With Launch of Oral GLP-1 for $49/mo! Better Than Our Best Hopes... -4%!

Hims Stock RALLIES! +13.50% in 1d... Was the Sell-off OVERDONE? Volatility = Price for High Returns!

Hims Q4 & 2025: Not Bad AT ALL! Still #1, Still Hyper Growth, 2030 Guidance Unchanged-WAY TOO CHEAP!

Hims Q1 Call: Bullish for Long-Term Investors, Mr. Market Hates It! Focus on Scale AI GLP1s Peptides

THE HIMS DISASTER: Is This Drop A Trap Or A Massive Opportunity?

Hims Stock: Short Squeeze Accelerates as Peptide Potential Sinks In—Hims Best Positioned to Win!

Hims & Hers Health | HIMS Stock Analysis with Elliott Wave + Trade Setup

Why Hims Is A Big Tech Company in the making (0-to-1, 10x) + Is Hims Stock A STEAL Right Now?